[
  {
    "id": 0,
    "question": "For clinical trial NCT02294461. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with E\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "ENZALUTAMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 1,
    "question": "First, for clinical trial NCT02294461 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ASTELLAS PHARMA US INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 2,
    "question": "First, for clinical trial NCT02294461 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Aug 13, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 3,
    "question": "For clinical trial NCT02294461 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Nov 17, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 4,
    "question": "For clinical trial NCT02294461, review the more effective regimen ingredients and identify which ingredient starts with the letter E.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "15.989999771118164",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 5,
    "question": "For clinical trial NCT00262769. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with G\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "GEMCITABINE HYDROCHLORIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 6,
    "question": "First, for clinical trial NCT00262769 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 7,
    "question": "First, for clinical trial NCT00262769 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 1, 2033",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 8,
    "question": "For clinical trial NCT00262769 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 9,
    "question": "For clinical trial NCT00262769, review the more effective regimen ingredients and identify which ingredient starts with the letter G.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 10,
    "question": "For clinical trial NCT02257736. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with AP\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "APALUTAMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 11,
    "question": "For clinical trial NCT02257736. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with AP.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "JANSSEN BIOTECH INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 12,
    "question": "For clinical trial NCT02257736. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with AP.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 13,
    "question": "For clinical trial NCT02257736 among the more effective regimen ingredients, identify which ingredient starts with the letter A.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 14,
    "question": "For clinical trial NCT02257736. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with AP.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "157.02000427246094",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 15,
    "question": "For clinical trial NCT03800134. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PEMETREXED DISODIUM",
    "task_name": "Ingredient"
  },
  {
    "id": 16,
    "question": "First, for clinical trial NCT03800134 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SHILPA MEDICARE LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 17,
    "question": "First, for clinical trial NCT03800134 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 18,
    "question": "For clinical trial NCT03800134 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 19,
    "question": "For clinical trial NCT03800134, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 20,
    "question": "For clinical trial NCT00974311. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with E\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "ENZALUTAMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 21,
    "question": "First, for clinical trial NCT00974311 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ASTELLAS PHARMA US INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 22,
    "question": "First, for clinical trial NCT00974311 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Aug 13, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 23,
    "question": "For clinical trial NCT00974311 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Nov 17, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 24,
    "question": "For clinical trial NCT00974311, review the more effective regimen ingredients and identify which ingredient starts with the letter E.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "15.989999771118164",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 25,
    "question": "For clinical trial NCT02838420. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with C\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "CRIZOTINIB",
    "task_name": "Ingredient"
  },
  {
    "id": 26,
    "question": "First, for clinical trial NCT02838420 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "PF PRISM CV",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 27,
    "question": "First, for clinical trial NCT02838420 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 12, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 28,
    "question": "For clinical trial NCT02838420 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Jul 14, 2025",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 29,
    "question": "For clinical trial NCT02838420, review the more effective regimen ingredients and identify which ingredient starts with the letter C.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "34.470001220703125",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 30,
    "question": "For clinical trial NCT01108445. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with E\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "EVEROLIMUS",
    "task_name": "Ingredient"
  },
  {
    "id": 31,
    "question": "First, for clinical trial NCT01108445 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "NOVARTIS PHARMACEUTICALS CORP",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 32,
    "question": "First, for clinical trial NCT01108445 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 1, 2026",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 33,
    "question": "For clinical trial NCT01108445 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 34,
    "question": "For clinical trial NCT01108445, review the more effective regimen ingredients and identify which ingredient starts with the letter E.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "49.51612854003906",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 35,
    "question": "For clinical trial NCT00355108. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with T\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "TRANEXAMIC ACID",
    "task_name": "Ingredient"
  },
  {
    "id": 36,
    "question": "First, for clinical trial NCT00355108 among the more effective regimen ingredients, identify which ingredient starts with the letter T.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "AMRING PHARMACEUTICALS INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 37,
    "question": "First, for clinical trial NCT00355108 among the more effective regimen ingredients, identify which ingredient starts with the letter T.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 4, 2025",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 38,
    "question": "For clinical trial NCT00355108 among the more effective regimen ingredients, identify which ingredient starts with the letter T.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 39,
    "question": "For clinical trial NCT00355108, review the more effective regimen ingredients and identify which ingredient starts with the letter T.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 40,
    "question": "For clinical trial NCT01938001. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with L\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "LENALIDOMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 41,
    "question": "First, for clinical trial NCT01938001 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 42,
    "question": "First, for clinical trial NCT01938001 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Apr 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 43,
    "question": "For clinical trial NCT01938001 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 28, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 44,
    "question": "For clinical trial NCT01938001, review the more effective regimen ingredients and identify which ingredient starts with the letter L.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "46.72999954223633",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 45,
    "question": "For clinical trial NCT00333775. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 46,
    "question": "First, for clinical trial NCT00333775 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 47,
    "question": "First, for clinical trial NCT00333775 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 48,
    "question": "For clinical trial NCT00333775 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 49,
    "question": "For clinical trial NCT00333775, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 50,
    "question": "For clinical trial NCT00391092. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 51,
    "question": "First, for clinical trial NCT00391092 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 52,
    "question": "First, for clinical trial NCT00391092 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 53,
    "question": "For clinical trial NCT00391092 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 54,
    "question": "For clinical trial NCT00391092, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 55,
    "question": "For clinical trial NCT00071799. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with A\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "AZACITIDINE",
    "task_name": "Ingredient"
  },
  {
    "id": 56,
    "question": "First, for clinical trial NCT00071799 among the more effective regimen ingredients, identify which ingredient starts with the letter A.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 57,
    "question": "First, for clinical trial NCT00071799 among the more effective regimen ingredients, identify which ingredient starts with the letter A.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 14, 2029",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 58,
    "question": "For clinical trial NCT00071799 among the more effective regimen ingredients, identify which ingredient starts with the letter A.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Sep 1, 2027",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 59,
    "question": "For clinical trial NCT00071799, review the more effective regimen ingredients and identify which ingredient starts with the letter A.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "62.20000076293945",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 60,
    "question": "For clinical trial NCT01949337. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with E\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "ENZALUTAMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 61,
    "question": "First, for clinical trial NCT01949337 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ASTELLAS PHARMA US INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 62,
    "question": "First, for clinical trial NCT01949337 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Aug 13, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 63,
    "question": "For clinical trial NCT01949337 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Nov 17, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 64,
    "question": "For clinical trial NCT01949337, review the more effective regimen ingredients and identify which ingredient starts with the letter E.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "15.989999771118164",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 65,
    "question": "For clinical trial NCT00021255. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 66,
    "question": "First, for clinical trial NCT00021255 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 67,
    "question": "First, for clinical trial NCT00021255 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 68,
    "question": "For clinical trial NCT00021255 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 69,
    "question": "For clinical trial NCT00021255, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 70,
    "question": "For clinical trial NCT00720512. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with I\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "IRINOTECAN HYDROCHLORIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 71,
    "question": "First, for clinical trial NCT00720512 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "IPSEN BIOPHARMACEUTICALS INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 72,
    "question": "First, for clinical trial NCT00720512 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 6, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 73,
    "question": "For clinical trial NCT00720512 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Feb 13, 2031",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 74,
    "question": "For clinical trial NCT00720512, review the more effective regimen ingredients and identify which ingredient starts with the letter I.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "15.140000343322754",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 75,
    "question": "For clinical trial NCT02755597. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with V\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "VENETOCLAX",
    "task_name": "Ingredient"
  },
  {
    "id": 76,
    "question": "First, for clinical trial NCT02755597 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ABBVIE INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 77,
    "question": "First, for clinical trial NCT02755597 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 29, 2032",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 78,
    "question": "For clinical trial NCT02755597 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 15, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 79,
    "question": "For clinical trial NCT02755597, review the more effective regimen ingredients and identify which ingredient starts with the letter V.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "58.59000015258789",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 80,
    "question": "For clinical trial NCT03110562. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with S\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "SELINEXOR",
    "task_name": "Ingredient"
  },
  {
    "id": 81,
    "question": "First, for clinical trial NCT03110562 among the more effective regimen ingredients, identify which ingredient starts with the letter S.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "KARYOPHARM THERAPEUTICS INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 82,
    "question": "First, for clinical trial NCT03110562 among the more effective regimen ingredients, identify which ingredient starts with the letter S.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 26, 2032",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 83,
    "question": "For clinical trial NCT03110562 among the more effective regimen ingredients, identify which ingredient starts with the letter S.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 84,
    "question": "For clinical trial NCT03110562, review the more effective regimen ingredients and identify which ingredient starts with the letter S.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "6.900000095367432",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 85,
    "question": "For clinical trial NCT01667419. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with V\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "VEMURAFENIB",
    "task_name": "Ingredient"
  },
  {
    "id": 86,
    "question": "First, for clinical trial NCT01667419 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "HOFFMANN LA ROCHE INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 87,
    "question": "First, for clinical trial NCT01667419 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Oct 22, 2026",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 88,
    "question": "For clinical trial NCT01667419 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 89,
    "question": "For clinical trial NCT01667419, review the more effective regimen ingredients and identify which ingredient starts with the letter V.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "21.139999389648438",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 90,
    "question": "For clinical trial NCT00003934. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with M\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "METHOTREXATE",
    "task_name": "Ingredient"
  },
  {
    "id": 91,
    "question": "First, for clinical trial NCT00003934 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "OTTER PHARMACEUTICALS LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 92,
    "question": "First, for clinical trial NCT00003934 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 24, 2026",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 93,
    "question": "For clinical trial NCT00003934 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 94,
    "question": "For clinical trial NCT00003934, review the more effective regimen ingredients and identify which ingredient starts with the letter M.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 95,
    "question": "For clinical trial NCT01478048. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with B\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "BORTEZOMIB",
    "task_name": "Ingredient"
  },
  {
    "id": 96,
    "question": "First, for clinical trial NCT01478048 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "FRESENIUS KABI USA LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 97,
    "question": "First, for clinical trial NCT01478048 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Nov 3, 2032",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 98,
    "question": "For clinical trial NCT01478048 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 99,
    "question": "For clinical trial NCT01478048, review the more effective regimen ingredients and identify which ingredient starts with the letter B.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "20.200000762939453",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 100,
    "question": "For clinical trial NCT00238238. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with L\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "LENALIDOMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 101,
    "question": "First, for clinical trial NCT00238238 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 102,
    "question": "First, for clinical trial NCT00238238 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Apr 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 103,
    "question": "For clinical trial NCT00238238 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 28, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 104,
    "question": "For clinical trial NCT00238238, review the more effective regimen ingredients and identify which ingredient starts with the letter L.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "46.72999954223633",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 105,
    "question": "For clinical trial NCT00833833. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DEXAMETHASONE",
    "task_name": "Ingredient"
  },
  {
    "id": 106,
    "question": "First, for clinical trial NCT00833833 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "DEXCEL PHARMA TECHNOLOGIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 107,
    "question": "First, for clinical trial NCT00833833 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 18, 2037",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 108,
    "question": "For clinical trial NCT00833833 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Oct 3, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 109,
    "question": "For clinical trial NCT00833833, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 110,
    "question": "For clinical trial NCT00005945. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with M\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "METHOTREXATE",
    "task_name": "Ingredient"
  },
  {
    "id": 111,
    "question": "First, for clinical trial NCT00005945 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "OTTER PHARMACEUTICALS LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 112,
    "question": "First, for clinical trial NCT00005945 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 24, 2026",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 113,
    "question": "For clinical trial NCT00005945 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 114,
    "question": "For clinical trial NCT00005945, review the more effective regimen ingredients and identify which ingredient starts with the letter M.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 115,
    "question": "For clinical trial NCT00978549. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 116,
    "question": "First, for clinical trial NCT00978549 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 117,
    "question": "First, for clinical trial NCT00978549 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 118,
    "question": "For clinical trial NCT00978549 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 119,
    "question": "For clinical trial NCT00978549, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 120,
    "question": "For clinical trial NCT01973387. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with I\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "IBRUTINIB",
    "task_name": "Ingredient"
  },
  {
    "id": 121,
    "question": "First, for clinical trial NCT01973387 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "PHARMACYCLICS LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 122,
    "question": "First, for clinical trial NCT01973387 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 3, 2031",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 123,
    "question": "For clinical trial NCT01973387 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Aug 24, 2029",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 124,
    "question": "For clinical trial NCT01973387, review the more effective regimen ingredients and identify which ingredient starts with the letter I.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 125,
    "question": "For clinical trial NCT00032175. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with G\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "GEMCITABINE HYDROCHLORIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 126,
    "question": "First, for clinical trial NCT00032175 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 127,
    "question": "First, for clinical trial NCT00032175 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 1, 2033",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 128,
    "question": "For clinical trial NCT00032175 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 129,
    "question": "For clinical trial NCT00032175, review the more effective regimen ingredients and identify which ingredient starts with the letter G.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 130,
    "question": "For clinical trial NCT02864251. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PEMETREXED DISODIUM",
    "task_name": "Ingredient"
  },
  {
    "id": 131,
    "question": "First, for clinical trial NCT02864251 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SHILPA MEDICARE LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 132,
    "question": "First, for clinical trial NCT02864251 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 133,
    "question": "For clinical trial NCT02864251 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 134,
    "question": "For clinical trial NCT02864251, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 135,
    "question": "For clinical trial NCT01197560. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with L\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "LENALIDOMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 136,
    "question": "First, for clinical trial NCT01197560 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 137,
    "question": "First, for clinical trial NCT01197560 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Apr 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 138,
    "question": "For clinical trial NCT01197560 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 28, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 139,
    "question": "For clinical trial NCT01197560, review the more effective regimen ingredients and identify which ingredient starts with the letter L.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "46.72999954223633",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 140,
    "question": "For clinical trial NCT00091442. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 141,
    "question": "First, for clinical trial NCT00091442 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 142,
    "question": "First, for clinical trial NCT00091442 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 143,
    "question": "For clinical trial NCT00091442 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 144,
    "question": "For clinical trial NCT00091442, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 145,
    "question": "For clinical trial NCT00033332. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DEXAMETHASONE",
    "task_name": "Ingredient"
  },
  {
    "id": 146,
    "question": "First, for clinical trial NCT00033332 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "DEXCEL PHARMA TECHNOLOGIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 147,
    "question": "First, for clinical trial NCT00033332 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 18, 2037",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 148,
    "question": "For clinical trial NCT00033332 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Oct 3, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 149,
    "question": "For clinical trial NCT00033332, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 150,
    "question": "For clinical trial NCT00843882. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with L\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "LENALIDOMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 151,
    "question": "First, for clinical trial NCT00843882 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 152,
    "question": "First, for clinical trial NCT00843882 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Apr 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 153,
    "question": "For clinical trial NCT00843882 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 28, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 154,
    "question": "For clinical trial NCT00843882, review the more effective regimen ingredients and identify which ingredient starts with the letter L.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "46.72999954223633",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 155,
    "question": "For clinical trial NCT00003013. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with M\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "METHOTREXATE",
    "task_name": "Ingredient"
  },
  {
    "id": 156,
    "question": "First, for clinical trial NCT00003013 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "OTTER PHARMACEUTICALS LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 157,
    "question": "First, for clinical trial NCT00003013 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 24, 2026",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 158,
    "question": "For clinical trial NCT00003013 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 159,
    "question": "For clinical trial NCT00003013, review the more effective regimen ingredients and identify which ingredient starts with the letter M.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 160,
    "question": "For clinical trial NCT00012389. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with I\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "IRINOTECAN HYDROCHLORIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 161,
    "question": "First, for clinical trial NCT00012389 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "IPSEN BIOPHARMACEUTICALS INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 162,
    "question": "First, for clinical trial NCT00012389 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 6, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 163,
    "question": "For clinical trial NCT00012389 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Feb 13, 2031",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 164,
    "question": "For clinical trial NCT00012389, review the more effective regimen ingredients and identify which ingredient starts with the letter I.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "15.140000343322754",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 165,
    "question": "For clinical trial NCT01193244. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PREDNISONE",
    "task_name": "Ingredient"
  },
  {
    "id": 166,
    "question": "First, for clinical trial NCT01193244 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "HORIZON THERAPEUTICS USA INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 167,
    "question": "First, for clinical trial NCT01193244 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Aug 3, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 168,
    "question": "For clinical trial NCT01193244 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 169,
    "question": "For clinical trial NCT01193244, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 170,
    "question": "For clinical trial NCT00003643. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PACLITAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 171,
    "question": "First, for clinical trial NCT00003643 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL-MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 172,
    "question": "First, for clinical trial NCT00003643 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 12, 2034",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 173,
    "question": "For clinical trial NCT00003643 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 174,
    "question": "For clinical trial NCT00003643, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "24.75",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 175,
    "question": "For clinical trial NCT00022191. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with G\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "GEMCITABINE HYDROCHLORIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 176,
    "question": "First, for clinical trial NCT00022191 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 177,
    "question": "First, for clinical trial NCT00022191 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 1, 2033",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 178,
    "question": "For clinical trial NCT00022191 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 179,
    "question": "For clinical trial NCT00022191, review the more effective regimen ingredients and identify which ingredient starts with the letter G.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 180,
    "question": "For clinical trial NCT00379041. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with M\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "MECHLORETHAMINE HYDROCHLORIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 181,
    "question": "First, for clinical trial NCT00379041 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "HELSINN BIREX PHARMACEUTICALS LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 182,
    "question": "First, for clinical trial NCT00379041 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 7, 2026",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 183,
    "question": "For clinical trial NCT00379041 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 184,
    "question": "For clinical trial NCT00379041, review the more effective regimen ingredients and identify which ingredient starts with the letter M.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 185,
    "question": "For clinical trial NCT00446225. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 186,
    "question": "First, for clinical trial NCT00446225 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 187,
    "question": "First, for clinical trial NCT00446225 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 188,
    "question": "For clinical trial NCT00446225 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 189,
    "question": "For clinical trial NCT00446225, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 190,
    "question": "For clinical trial NCT00416507. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with G\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "GEMCITABINE HYDROCHLORIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 191,
    "question": "First, for clinical trial NCT00416507 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 192,
    "question": "First, for clinical trial NCT00416507 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 1, 2033",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 193,
    "question": "For clinical trial NCT00416507 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 194,
    "question": "For clinical trial NCT00416507, review the more effective regimen ingredients and identify which ingredient starts with the letter G.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 195,
    "question": "For clinical trial NCT01231412. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with S\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "SIROLIMUS",
    "task_name": "Ingredient"
  },
  {
    "id": 196,
    "question": "First, for clinical trial NCT01231412 among the more effective regimen ingredients, identify which ingredient starts with the letter S.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "AADI SUBSIDIARY INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 197,
    "question": "First, for clinical trial NCT01231412 among the more effective regimen ingredients, identify which ingredient starts with the letter S.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 5, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 198,
    "question": "For clinical trial NCT01231412 among the more effective regimen ingredients, identify which ingredient starts with the letter S.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Nov 22, 2028",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 199,
    "question": "For clinical trial NCT01231412, review the more effective regimen ingredients and identify which ingredient starts with the letter S.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "25.06999969482422",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 200,
    "question": "For clinical trial NCT02203643. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with C\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "CARFILZOMIB",
    "task_name": "Ingredient"
  },
  {
    "id": 201,
    "question": "First, for clinical trial NCT02203643 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ONYX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF AMGEN INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 202,
    "question": "First, for clinical trial NCT02203643 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Apr 14, 2025",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 203,
    "question": "For clinical trial NCT02203643 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 204,
    "question": "For clinical trial NCT02203643, review the more effective regimen ingredients and identify which ingredient starts with the letter C.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 205,
    "question": "For clinical trial NCT02950051. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with V\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "VENETOCLAX",
    "task_name": "Ingredient"
  },
  {
    "id": 206,
    "question": "First, for clinical trial NCT02950051 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ABBVIE INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 207,
    "question": "First, for clinical trial NCT02950051 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 29, 2032",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 208,
    "question": "For clinical trial NCT02950051 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 15, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 209,
    "question": "For clinical trial NCT02950051, review the more effective regimen ingredients and identify which ingredient starts with the letter V.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "58.59000015258789",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 210,
    "question": "For clinical trial NCT01296503. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DEXAMETHASONE",
    "task_name": "Ingredient"
  },
  {
    "id": 211,
    "question": "First, for clinical trial NCT01296503 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "DEXCEL PHARMA TECHNOLOGIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 212,
    "question": "First, for clinical trial NCT01296503 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 18, 2037",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 213,
    "question": "For clinical trial NCT01296503 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Oct 3, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 214,
    "question": "For clinical trial NCT01296503, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 215,
    "question": "For clinical trial NCT01556776. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with L\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "LENALIDOMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 216,
    "question": "First, for clinical trial NCT01556776 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 217,
    "question": "First, for clinical trial NCT01556776 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Apr 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 218,
    "question": "For clinical trial NCT01556776 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 28, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 219,
    "question": "For clinical trial NCT01556776, review the more effective regimen ingredients and identify which ingredient starts with the letter L.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "46.72999954223633",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 220,
    "question": "For clinical trial NCT00121992. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 221,
    "question": "First, for clinical trial NCT00121992 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 222,
    "question": "First, for clinical trial NCT00121992 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 223,
    "question": "For clinical trial NCT00121992 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 224,
    "question": "For clinical trial NCT00121992, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 225,
    "question": "For clinical trial NCT02301156. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with I\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "IBRUTINIB",
    "task_name": "Ingredient"
  },
  {
    "id": 226,
    "question": "First, for clinical trial NCT02301156 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "PHARMACYCLICS LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 227,
    "question": "First, for clinical trial NCT02301156 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 3, 2031",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 228,
    "question": "For clinical trial NCT02301156 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Aug 24, 2029",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 229,
    "question": "For clinical trial NCT02301156, review the more effective regimen ingredients and identify which ingredient starts with the letter I.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 230,
    "question": "For clinical trial NCT01718379. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with L\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "LENALIDOMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 231,
    "question": "First, for clinical trial NCT01718379 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 232,
    "question": "First, for clinical trial NCT01718379 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Apr 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 233,
    "question": "For clinical trial NCT01718379 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 28, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 234,
    "question": "For clinical trial NCT01718379, review the more effective regimen ingredients and identify which ingredient starts with the letter L.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "46.72999954223633",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 235,
    "question": "For clinical trial NCT00003702. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with M\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "METHOTREXATE",
    "task_name": "Ingredient"
  },
  {
    "id": 236,
    "question": "First, for clinical trial NCT00003702 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "OTTER PHARMACEUTICALS LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 237,
    "question": "First, for clinical trial NCT00003702 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 24, 2026",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 238,
    "question": "For clinical trial NCT00003702 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 239,
    "question": "For clinical trial NCT00003702, review the more effective regimen ingredients and identify which ingredient starts with the letter M.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 240,
    "question": "For clinical trial NCT00003128. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PACLITAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 241,
    "question": "First, for clinical trial NCT00003128 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL-MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 242,
    "question": "First, for clinical trial NCT00003128 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 12, 2034",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 243,
    "question": "For clinical trial NCT00003128 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 244,
    "question": "For clinical trial NCT00003128, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "24.75",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 245,
    "question": "For clinical trial NCT00003691. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PACLITAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 246,
    "question": "First, for clinical trial NCT00003691 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL-MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 247,
    "question": "First, for clinical trial NCT00003691 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 12, 2034",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 248,
    "question": "For clinical trial NCT00003691 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 249,
    "question": "For clinical trial NCT00003691, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "24.75",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 250,
    "question": "For clinical trial NCT00064077. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PACLITAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 251,
    "question": "First, for clinical trial NCT00064077 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL-MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 252,
    "question": "First, for clinical trial NCT00064077 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 12, 2034",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 253,
    "question": "For clinical trial NCT00064077 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 254,
    "question": "For clinical trial NCT00064077, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "24.75",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 255,
    "question": "For clinical trial NCT01924533. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with O\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "OLAPARIB",
    "task_name": "Ingredient"
  },
  {
    "id": 256,
    "question": "First, for clinical trial NCT01924533 among the more effective regimen ingredients, identify which ingredient starts with the letter O.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ASTRAZENECA PHARMACEUTICALS LP",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 257,
    "question": "First, for clinical trial NCT01924533 among the more effective regimen ingredients, identify which ingredient starts with the letter O.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Aug 12, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 258,
    "question": "For clinical trial NCT01924533 among the more effective regimen ingredients, identify which ingredient starts with the letter O.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 259,
    "question": "For clinical trial NCT01924533, review the more effective regimen ingredients and identify which ingredient starts with the letter O.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "35.55500030517578",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 260,
    "question": "For clinical trial NCT01251107. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PREDNISONE",
    "task_name": "Ingredient"
  },
  {
    "id": 261,
    "question": "First, for clinical trial NCT01251107 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "HORIZON THERAPEUTICS USA INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 262,
    "question": "First, for clinical trial NCT01251107 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Aug 3, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 263,
    "question": "For clinical trial NCT01251107 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 264,
    "question": "For clinical trial NCT01251107, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 265,
    "question": "For clinical trial NCT00424606. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 266,
    "question": "First, for clinical trial NCT00424606 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 267,
    "question": "First, for clinical trial NCT00424606 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 268,
    "question": "For clinical trial NCT00424606 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 269,
    "question": "For clinical trial NCT00424606, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 270,
    "question": "For clinical trial NCT00441922. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 271,
    "question": "First, for clinical trial NCT00441922 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 272,
    "question": "First, for clinical trial NCT00441922 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 273,
    "question": "For clinical trial NCT00441922 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 274,
    "question": "For clinical trial NCT00441922, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 275,
    "question": "For clinical trial NCT00012051. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DEXAMETHASONE",
    "task_name": "Ingredient"
  },
  {
    "id": 276,
    "question": "First, for clinical trial NCT00012051 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "DEXCEL PHARMA TECHNOLOGIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 277,
    "question": "First, for clinical trial NCT00012051 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 18, 2037",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 278,
    "question": "For clinical trial NCT00012051 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Oct 3, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 279,
    "question": "For clinical trial NCT00012051, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 280,
    "question": "For clinical trial NCT00344526. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DEXAMETHASONE",
    "task_name": "Ingredient"
  },
  {
    "id": 281,
    "question": "First, for clinical trial NCT00344526 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "DEXCEL PHARMA TECHNOLOGIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 282,
    "question": "First, for clinical trial NCT00344526 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 18, 2037",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 283,
    "question": "For clinical trial NCT00344526 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Oct 3, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 284,
    "question": "For clinical trial NCT00344526, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 285,
    "question": "For clinical trial NCT00430365. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with L\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "LENALIDOMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 286,
    "question": "First, for clinical trial NCT00430365 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 287,
    "question": "First, for clinical trial NCT00430365 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Apr 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 288,
    "question": "For clinical trial NCT00430365 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 28, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 289,
    "question": "For clinical trial NCT00430365, review the more effective regimen ingredients and identify which ingredient starts with the letter L.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "46.72999954223633",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 290,
    "question": "For clinical trial NCT00478049. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 291,
    "question": "First, for clinical trial NCT00478049 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 292,
    "question": "First, for clinical trial NCT00478049 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 293,
    "question": "For clinical trial NCT00478049 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 294,
    "question": "For clinical trial NCT00478049, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 295,
    "question": "For clinical trial NCT01356511. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DEXAMETHASONE",
    "task_name": "Ingredient"
  },
  {
    "id": 296,
    "question": "First, for clinical trial NCT01356511 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "DEXCEL PHARMA TECHNOLOGIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 297,
    "question": "First, for clinical trial NCT01356511 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 18, 2037",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 298,
    "question": "For clinical trial NCT01356511 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Oct 3, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 299,
    "question": "For clinical trial NCT01356511, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 300,
    "question": "For clinical trial NCT01282463. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 301,
    "question": "First, for clinical trial NCT01282463 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 302,
    "question": "First, for clinical trial NCT01282463 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 303,
    "question": "For clinical trial NCT01282463 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 304,
    "question": "For clinical trial NCT01282463, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 305,
    "question": "For clinical trial NCT00190762. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PEMETREXED DISODIUM",
    "task_name": "Ingredient"
  },
  {
    "id": 306,
    "question": "First, for clinical trial NCT00190762 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SHILPA MEDICARE LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 307,
    "question": "First, for clinical trial NCT00190762 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 308,
    "question": "For clinical trial NCT00190762 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 309,
    "question": "For clinical trial NCT00190762, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 310,
    "question": "For clinical trial NCT00363415. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PEMETREXED DISODIUM",
    "task_name": "Ingredient"
  },
  {
    "id": 311,
    "question": "First, for clinical trial NCT00363415 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SHILPA MEDICARE LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 312,
    "question": "First, for clinical trial NCT00363415 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 313,
    "question": "For clinical trial NCT00363415 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 314,
    "question": "For clinical trial NCT00363415, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 315,
    "question": "For clinical trial NCT01469000. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PEMETREXED DISODIUM",
    "task_name": "Ingredient"
  },
  {
    "id": 316,
    "question": "First, for clinical trial NCT01469000 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SHILPA MEDICARE LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 317,
    "question": "First, for clinical trial NCT01469000 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 318,
    "question": "For clinical trial NCT01469000 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 319,
    "question": "For clinical trial NCT01469000, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 320,
    "question": "For clinical trial NCT03019588. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PACLITAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 321,
    "question": "First, for clinical trial NCT03019588 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL-MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 322,
    "question": "First, for clinical trial NCT03019588 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 12, 2034",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 323,
    "question": "For clinical trial NCT03019588 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 324,
    "question": "For clinical trial NCT03019588, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "24.75",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 325,
    "question": "For clinical trial NCT03425643. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PEMETREXED DISODIUM",
    "task_name": "Ingredient"
  },
  {
    "id": 326,
    "question": "First, for clinical trial NCT03425643 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SHILPA MEDICARE LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 327,
    "question": "First, for clinical trial NCT03425643 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 328,
    "question": "For clinical trial NCT03425643 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 329,
    "question": "For clinical trial NCT03425643, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 330,
    "question": "For clinical trial NCT03234972. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DEXAMETHASONE",
    "task_name": "Ingredient"
  },
  {
    "id": 331,
    "question": "First, for clinical trial NCT03234972 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "DEXCEL PHARMA TECHNOLOGIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 332,
    "question": "First, for clinical trial NCT03234972 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 18, 2037",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 333,
    "question": "For clinical trial NCT03234972 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Oct 3, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 334,
    "question": "For clinical trial NCT03234972, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 335,
    "question": "For clinical trial NCT02162719. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PACLITAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 336,
    "question": "First, for clinical trial NCT02162719 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL-MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 337,
    "question": "First, for clinical trial NCT02162719 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 12, 2034",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 338,
    "question": "For clinical trial NCT02162719 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 339,
    "question": "For clinical trial NCT02162719, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "24.75",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 340,
    "question": "For clinical trial NCT00806819. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PEMETREXED DISODIUM",
    "task_name": "Ingredient"
  },
  {
    "id": 341,
    "question": "First, for clinical trial NCT00806819 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SHILPA MEDICARE LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 342,
    "question": "First, for clinical trial NCT00806819 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 343,
    "question": "For clinical trial NCT00806819 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 344,
    "question": "For clinical trial NCT00806819, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 345,
    "question": "For clinical trial NCT01345682. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with M\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "METHOTREXATE",
    "task_name": "Ingredient"
  },
  {
    "id": 346,
    "question": "First, for clinical trial NCT01345682 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "OTTER PHARMACEUTICALS LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 347,
    "question": "First, for clinical trial NCT01345682 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 24, 2026",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 348,
    "question": "For clinical trial NCT01345682 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 349,
    "question": "For clinical trial NCT01345682, review the more effective regimen ingredients and identify which ingredient starts with the letter M.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 350,
    "question": "For clinical trial NCT01856478. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with M\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "METHOTREXATE",
    "task_name": "Ingredient"
  },
  {
    "id": 351,
    "question": "First, for clinical trial NCT01856478 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "OTTER PHARMACEUTICALS LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 352,
    "question": "First, for clinical trial NCT01856478 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 24, 2026",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 353,
    "question": "For clinical trial NCT01856478 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 354,
    "question": "For clinical trial NCT01856478, review the more effective regimen ingredients and identify which ingredient starts with the letter M.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 355,
    "question": "For clinical trial NCT04988295. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PEMETREXED DISODIUM",
    "task_name": "Ingredient"
  },
  {
    "id": 356,
    "question": "First, for clinical trial NCT04988295 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SHILPA MEDICARE LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 357,
    "question": "First, for clinical trial NCT04988295 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 358,
    "question": "For clinical trial NCT04988295 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 359,
    "question": "For clinical trial NCT04988295, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 360,
    "question": "For clinical trial NCT01720225. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with A\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "AZACITIDINE",
    "task_name": "Ingredient"
  },
  {
    "id": 361,
    "question": "First, for clinical trial NCT01720225 among the more effective regimen ingredients, identify which ingredient starts with the letter A.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 362,
    "question": "First, for clinical trial NCT01720225 among the more effective regimen ingredients, identify which ingredient starts with the letter A.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 14, 2029",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 363,
    "question": "For clinical trial NCT01720225 among the more effective regimen ingredients, identify which ingredient starts with the letter A.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Sep 1, 2027",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 364,
    "question": "For clinical trial NCT01720225, review the more effective regimen ingredients and identify which ingredient starts with the letter A.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "62.20000076293945",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 365,
    "question": "For clinical trial NCT01029262. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with L\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "LENALIDOMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 366,
    "question": "First, for clinical trial NCT01029262 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 367,
    "question": "First, for clinical trial NCT01029262 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Apr 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 368,
    "question": "For clinical trial NCT01029262 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 28, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 369,
    "question": "For clinical trial NCT01029262, review the more effective regimen ingredients and identify which ingredient starts with the letter L.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "46.72999954223633",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 370,
    "question": "For clinical trial NCT00256776. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DEXAMETHASONE",
    "task_name": "Ingredient"
  },
  {
    "id": 371,
    "question": "First, for clinical trial NCT00256776 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "DEXCEL PHARMA TECHNOLOGIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 372,
    "question": "First, for clinical trial NCT00256776 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 18, 2037",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 373,
    "question": "For clinical trial NCT00256776 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Oct 3, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 374,
    "question": "For clinical trial NCT00256776, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 375,
    "question": "For clinical trial NCT00079274. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with I\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "IRINOTECAN HYDROCHLORIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 376,
    "question": "First, for clinical trial NCT00079274 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "IPSEN BIOPHARMACEUTICALS INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 377,
    "question": "First, for clinical trial NCT00079274 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 6, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 378,
    "question": "For clinical trial NCT00079274 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Feb 13, 2031",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 379,
    "question": "For clinical trial NCT00079274, review the more effective regimen ingredients and identify which ingredient starts with the letter I.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 380,
    "question": "For clinical trial NCT03838159. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PACLITAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 381,
    "question": "First, for clinical trial NCT03838159 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL-MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 382,
    "question": "First, for clinical trial NCT03838159 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 12, 2034",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 383,
    "question": "For clinical trial NCT03838159 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 384,
    "question": "For clinical trial NCT03838159, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "24.75",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 385,
    "question": "For clinical trial NCT00004100. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with G\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "GEMCITABINE HYDROCHLORIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 386,
    "question": "First, for clinical trial NCT00004100 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 387,
    "question": "First, for clinical trial NCT00004100 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 1, 2033",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 388,
    "question": "For clinical trial NCT00004100 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 389,
    "question": "For clinical trial NCT00004100, review the more effective regimen ingredients and identify which ingredient starts with the letter G.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 390,
    "question": "For clinical trial NCT00026338. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with G\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "GEMCITABINE HYDROCHLORIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 391,
    "question": "First, for clinical trial NCT00026338 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 392,
    "question": "First, for clinical trial NCT00026338 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 1, 2033",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 393,
    "question": "For clinical trial NCT00026338 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 394,
    "question": "For clinical trial NCT00026338, review the more effective regimen ingredients and identify which ingredient starts with the letter G.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 395,
    "question": "For clinical trial NCT00002582. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with C\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "CYCLOPHOSPHAMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 396,
    "question": "First, for clinical trial NCT00002582 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "EUGIA PHARMA SPECIALITIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 397,
    "question": "First, for clinical trial NCT00002582 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jun 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 398,
    "question": "For clinical trial NCT00002582 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 399,
    "question": "For clinical trial NCT00002582, review the more effective regimen ingredients and identify which ingredient starts with the letter C.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 400,
    "question": "For clinical trial NCT00513955. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with B\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "BORTEZOMIB",
    "task_name": "Ingredient"
  },
  {
    "id": 401,
    "question": "First, for clinical trial NCT00513955 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "FRESENIUS KABI USA LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 402,
    "question": "First, for clinical trial NCT00513955 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Nov 3, 2032",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 403,
    "question": "For clinical trial NCT00513955 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 404,
    "question": "For clinical trial NCT00513955, review the more effective regimen ingredients and identify which ingredient starts with the letter B.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "20.200000762939453",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 405,
    "question": "For clinical trial NCT00260689. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with C\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "CYCLOSPORINE",
    "task_name": "Ingredient"
  },
  {
    "id": 406,
    "question": "First, for clinical trial NCT00260689 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ABBVIE INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 407,
    "question": "First, for clinical trial NCT00260689 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Feb 25, 2031",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 408,
    "question": "For clinical trial NCT00260689 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 409,
    "question": "For clinical trial NCT00260689, review the more effective regimen ingredients and identify which ingredient starts with the letter C.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "61.45000076293945",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 410,
    "question": "For clinical trial NCT01998503. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with B\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "BORTEZOMIB",
    "task_name": "Ingredient"
  },
  {
    "id": 411,
    "question": "First, for clinical trial NCT01998503 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "FRESENIUS KABI USA LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 412,
    "question": "First, for clinical trial NCT01998503 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Nov 3, 2032",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 413,
    "question": "For clinical trial NCT01998503 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 414,
    "question": "For clinical trial NCT01998503, review the more effective regimen ingredients and identify which ingredient starts with the letter B.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 415,
    "question": "For clinical trial NCT00417911. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with B\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "BORTEZOMIB",
    "task_name": "Ingredient"
  },
  {
    "id": 416,
    "question": "First, for clinical trial NCT00417911 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "FRESENIUS KABI USA LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 417,
    "question": "First, for clinical trial NCT00417911 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Nov 3, 2032",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 418,
    "question": "For clinical trial NCT00417911 among the more effective regimen ingredients, identify which ingredient starts with the letter B.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 419,
    "question": "For clinical trial NCT00417911, review the more effective regimen ingredients and identify which ingredient starts with the letter B.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "20.200000762939453",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 420,
    "question": "For clinical trial NCT00003782. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 421,
    "question": "First, for clinical trial NCT00003782 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 422,
    "question": "First, for clinical trial NCT00003782 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 423,
    "question": "For clinical trial NCT00003782 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 424,
    "question": "For clinical trial NCT00003782, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 425,
    "question": "For clinical trial NCT02775006. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 426,
    "question": "First, for clinical trial NCT02775006 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 427,
    "question": "First, for clinical trial NCT02775006 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 428,
    "question": "For clinical trial NCT02775006 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 429,
    "question": "For clinical trial NCT02775006, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 430,
    "question": "For clinical trial NCT03150875. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 431,
    "question": "First, for clinical trial NCT03150875 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 432,
    "question": "First, for clinical trial NCT03150875 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 433,
    "question": "For clinical trial NCT03150875 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 434,
    "question": "For clinical trial NCT03150875, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 435,
    "question": "For clinical trial NCT00718549. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with C\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "CLADRIBINE",
    "task_name": "Ingredient"
  },
  {
    "id": 436,
    "question": "First, for clinical trial NCT00718549 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "EMD SERONO INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 437,
    "question": "First, for clinical trial NCT00718549 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 31, 2026",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 438,
    "question": "For clinical trial NCT00718549 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 439,
    "question": "For clinical trial NCT00718549, review the more effective regimen ingredients and identify which ingredient starts with the letter C.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "22.75",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 440,
    "question": "For clinical trial NCT04538664. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PEMETREXED DISODIUM",
    "task_name": "Ingredient"
  },
  {
    "id": 441,
    "question": "First, for clinical trial NCT04538664 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SHILPA MEDICARE LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 442,
    "question": "First, for clinical trial NCT04538664 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 443,
    "question": "For clinical trial NCT04538664 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 444,
    "question": "For clinical trial NCT04538664, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 445,
    "question": "For clinical trial NCT03588091. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 446,
    "question": "First, for clinical trial NCT03588091 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 447,
    "question": "First, for clinical trial NCT03588091 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 448,
    "question": "For clinical trial NCT03588091 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 449,
    "question": "For clinical trial NCT03588091, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 450,
    "question": "For clinical trial NCT02288247. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with E\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "ENZALUTAMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 451,
    "question": "First, for clinical trial NCT02288247 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ASTELLAS PHARMA US INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 452,
    "question": "First, for clinical trial NCT02288247 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Aug 13, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 453,
    "question": "For clinical trial NCT02288247 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Nov 17, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 454,
    "question": "For clinical trial NCT02288247, review the more effective regimen ingredients and identify which ingredient starts with the letter E.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "15.989999771118164",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 455,
    "question": "For clinical trial NCT03009981. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with AP\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "APALUTAMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 456,
    "question": "For clinical trial NCT03009981. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with AP.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "JANSSEN BIOTECH INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 457,
    "question": "For clinical trial NCT03009981. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with AP.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Mar 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 458,
    "question": "For clinical trial NCT03009981 among the more effective regimen ingredients, identify which ingredient starts with the letter A.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 459,
    "question": "For clinical trial NCT03009981. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with AP.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "157.02000427246094",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 460,
    "question": "For clinical trial NCT01639001. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with C\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "CRIZOTINIB",
    "task_name": "Ingredient"
  },
  {
    "id": 461,
    "question": "First, for clinical trial NCT01639001 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "PF PRISM CV",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 462,
    "question": "First, for clinical trial NCT01639001 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 12, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 463,
    "question": "For clinical trial NCT01639001 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Jul 14, 2025",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 464,
    "question": "For clinical trial NCT01639001, review the more effective regimen ingredients and identify which ingredient starts with the letter C.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "34.470001220703125",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 465,
    "question": "For clinical trial NCT00002870. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with T\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "THIOTEPA",
    "task_name": "Ingredient"
  },
  {
    "id": 466,
    "question": "First, for clinical trial NCT00002870 among the more effective regimen ingredients, identify which ingredient starts with the letter T.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SHORLA PHARMA LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 467,
    "question": "First, for clinical trial NCT00002870 among the more effective regimen ingredients, identify which ingredient starts with the letter T.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Aug 16, 2041",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 468,
    "question": "For clinical trial NCT00002870 among the more effective regimen ingredients, identify which ingredient starts with the letter T.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 469,
    "question": "For clinical trial NCT00002870, review the more effective regimen ingredients and identify which ingredient starts with the letter T.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 470,
    "question": "For clinical trial NCT02898077. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PACLITAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 471,
    "question": "First, for clinical trial NCT02898077 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL-MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 472,
    "question": "First, for clinical trial NCT02898077 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 12, 2034",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 473,
    "question": "For clinical trial NCT02898077 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 474,
    "question": "For clinical trial NCT02898077, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "24.75",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 475,
    "question": "For clinical trial NCT00651261. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with M\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "MIDOSTAURIN",
    "task_name": "Ingredient"
  },
  {
    "id": 476,
    "question": "First, for clinical trial NCT00651261 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "NOVARTIS PHARMACEUTICALS CORP",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 477,
    "question": "First, for clinical trial NCT00651261 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Oct 9, 2028",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 478,
    "question": "For clinical trial NCT00651261 among the more effective regimen ingredients, identify which ingredient starts with the letter M.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 479,
    "question": "For clinical trial NCT00651261, review the more effective regimen ingredients and identify which ingredient starts with the letter M.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "68.68279266357422",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 480,
    "question": "For clinical trial NCT00090051. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with C\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "CYCLOPHOSPHAMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 481,
    "question": "First, for clinical trial NCT00090051 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "EUGIA PHARMA SPECIALITIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 482,
    "question": "First, for clinical trial NCT00090051 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jun 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 483,
    "question": "For clinical trial NCT00090051 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 484,
    "question": "For clinical trial NCT00090051, review the more effective regimen ingredients and identify which ingredient starts with the letter C.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 485,
    "question": "For clinical trial NCT01122472. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with L\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "LENALIDOMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 486,
    "question": "First, for clinical trial NCT01122472 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 487,
    "question": "First, for clinical trial NCT01122472 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Apr 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 488,
    "question": "For clinical trial NCT01122472 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 28, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 489,
    "question": "For clinical trial NCT01122472, review the more effective regimen ingredients and identify which ingredient starts with the letter L.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "46.72999954223633",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 490,
    "question": "For clinical trial NCT01168973. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 491,
    "question": "First, for clinical trial NCT01168973 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 492,
    "question": "First, for clinical trial NCT01168973 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 493,
    "question": "For clinical trial NCT01168973 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 494,
    "question": "For clinical trial NCT01168973, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 495,
    "question": "For clinical trial NCT00052936. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PREDNISONE",
    "task_name": "Ingredient"
  },
  {
    "id": 496,
    "question": "First, for clinical trial NCT00052936 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "HORIZON THERAPEUTICS USA INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 497,
    "question": "First, for clinical trial NCT00052936 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Aug 3, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 498,
    "question": "For clinical trial NCT00052936 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 499,
    "question": "For clinical trial NCT00052936, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 500,
    "question": "For clinical trial NCT00703326. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 501,
    "question": "First, for clinical trial NCT00703326 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 502,
    "question": "First, for clinical trial NCT00703326 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 503,
    "question": "For clinical trial NCT00703326 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 504,
    "question": "For clinical trial NCT00703326, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 505,
    "question": "For clinical trial NCT00084318. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 506,
    "question": "First, for clinical trial NCT00084318 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 507,
    "question": "First, for clinical trial NCT00084318 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 508,
    "question": "For clinical trial NCT00084318 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 509,
    "question": "For clinical trial NCT00084318, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 510,
    "question": "For clinical trial NCT01307605. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with L\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "LENALIDOMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 511,
    "question": "First, for clinical trial NCT01307605 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL MYERS SQUIBB",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 512,
    "question": "First, for clinical trial NCT01307605 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Apr 27, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 513,
    "question": "For clinical trial NCT01307605 among the more effective regimen ingredients, identify which ingredient starts with the letter L.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 28, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 514,
    "question": "For clinical trial NCT01307605, review the more effective regimen ingredients and identify which ingredient starts with the letter L.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "46.72999954223633",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 515,
    "question": "For clinical trial NCT02340221. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with F\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "FULVESTRANT",
    "task_name": "Ingredient"
  },
  {
    "id": 516,
    "question": "First, for clinical trial NCT02340221 among the more effective regimen ingredients, identify which ingredient starts with the letter F.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "FRESENIUS KABI USA LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 517,
    "question": "First, for clinical trial NCT02340221 among the more effective regimen ingredients, identify which ingredient starts with the letter F.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Feb 14, 2034",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 518,
    "question": "For clinical trial NCT02340221 among the more effective regimen ingredients, identify which ingredient starts with the letter F.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 519,
    "question": "For clinical trial NCT02340221, review the more effective regimen ingredients and identify which ingredient starts with the letter F.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "13.229999542236328",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 520,
    "question": "For clinical trial NCT02048371. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with R\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "REGORAFENIB",
    "task_name": "Ingredient"
  },
  {
    "id": 521,
    "question": "First, for clinical trial NCT02048371 among the more effective regimen ingredients, identify which ingredient starts with the letter R.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BAYER HEALTHCARE PHARMACEUTICALS INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 522,
    "question": "First, for clinical trial NCT02048371 among the more effective regimen ingredients, identify which ingredient starts with the letter R.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Feb 16, 2031",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 523,
    "question": "For clinical trial NCT02048371 among the more effective regimen ingredients, identify which ingredient starts with the letter R.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 524,
    "question": "For clinical trial NCT02048371, review the more effective regimen ingredients and identify which ingredient starts with the letter R.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "21.915000915527344",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 525,
    "question": "For clinical trial NCT01776840. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with I\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "IBRUTINIB",
    "task_name": "Ingredient"
  },
  {
    "id": 526,
    "question": "First, for clinical trial NCT01776840 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "PHARMACYCLICS LLC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 527,
    "question": "First, for clinical trial NCT01776840 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 3, 2031",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 528,
    "question": "For clinical trial NCT01776840 among the more effective regimen ingredients, identify which ingredient starts with the letter I.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Aug 24, 2029",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 529,
    "question": "For clinical trial NCT01776840, review the more effective regimen ingredients and identify which ingredient starts with the letter I.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 530,
    "question": "For clinical trial NCT00376792. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 531,
    "question": "First, for clinical trial NCT00376792 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 532,
    "question": "First, for clinical trial NCT00376792 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 533,
    "question": "For clinical trial NCT00376792 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 534,
    "question": "For clinical trial NCT00376792, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 535,
    "question": "For clinical trial NCT00445601. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with G\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "GEMCITABINE HYDROCHLORIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 536,
    "question": "First, for clinical trial NCT00445601 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 537,
    "question": "First, for clinical trial NCT00445601 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 1, 2033",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 538,
    "question": "For clinical trial NCT00445601 among the more effective regimen ingredients, identify which ingredient starts with the letter G.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 539,
    "question": "For clinical trial NCT00445601, review the more effective regimen ingredients and identify which ingredient starts with the letter G.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 540,
    "question": "For clinical trial NCT00004001. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PREDNISONE",
    "task_name": "Ingredient"
  },
  {
    "id": 541,
    "question": "First, for clinical trial NCT00004001 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "HORIZON THERAPEUTICS USA INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 542,
    "question": "First, for clinical trial NCT00004001 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Aug 3, 2027",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 543,
    "question": "For clinical trial NCT00004001 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 544,
    "question": "For clinical trial NCT00004001, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 545,
    "question": "For clinical trial NCT02672527. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with T\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "TRABECTEDIN",
    "task_name": "Ingredient"
  },
  {
    "id": 546,
    "question": "First, for clinical trial NCT02672527 among the more effective regimen ingredients, identify which ingredient starts with the letter T.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "JANSSEN PRODUCTS LP",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 547,
    "question": "First, for clinical trial NCT02672527 among the more effective regimen ingredients, identify which ingredient starts with the letter T.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 7, 2028",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 548,
    "question": "For clinical trial NCT02672527 among the more effective regimen ingredients, identify which ingredient starts with the letter T.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 549,
    "question": "For clinical trial NCT02672527, review the more effective regimen ingredients and identify which ingredient starts with the letter T.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "99.87999725341797",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 550,
    "question": "For clinical trial NCT01298713. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with E\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "EVEROLIMUS",
    "task_name": "Ingredient"
  },
  {
    "id": 551,
    "question": "First, for clinical trial NCT01298713 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "NOVARTIS PHARMACEUTICALS CORP",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 552,
    "question": "First, for clinical trial NCT01298713 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 1, 2026",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 553,
    "question": "For clinical trial NCT01298713 among the more effective regimen ingredients, identify which ingredient starts with the letter E.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 554,
    "question": "For clinical trial NCT01298713, review the more effective regimen ingredients and identify which ingredient starts with the letter E.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "49.51612854003906",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 555,
    "question": "For clinical trial NCT03117049. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PACLITAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 556,
    "question": "First, for clinical trial NCT03117049 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL-MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 557,
    "question": "First, for clinical trial NCT03117049 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 12, 2034",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 558,
    "question": "For clinical trial NCT03117049 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 559,
    "question": "For clinical trial NCT03117049, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "24.75",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 560,
    "question": "For clinical trial NCT00002662. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with P\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "PACLITAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 561,
    "question": "First, for clinical trial NCT00002662 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "BRISTOL-MYERS SQUIBB CO",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 562,
    "question": "First, for clinical trial NCT00002662 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jul 12, 2034",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 563,
    "question": "For clinical trial NCT00002662 among the more effective regimen ingredients, identify which ingredient starts with the letter P.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 564,
    "question": "For clinical trial NCT00002662, review the more effective regimen ingredients and identify which ingredient starts with the letter P.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "24.75",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 565,
    "question": "For clinical trial NCT01038661. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DOCETAXEL",
    "task_name": "Ingredient"
  },
  {
    "id": 566,
    "question": "First, for clinical trial NCT01038661 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ZHUHAI BEIHAI BIOTECH CO LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 567,
    "question": "First, for clinical trial NCT01038661 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "May 16, 2036",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 568,
    "question": "For clinical trial NCT01038661 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 569,
    "question": "For clinical trial NCT01038661, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 570,
    "question": "For clinical trial NCT01564537. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DEXAMETHASONE",
    "task_name": "Ingredient"
  },
  {
    "id": 571,
    "question": "First, for clinical trial NCT01564537 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "DEXCEL PHARMA TECHNOLOGIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 572,
    "question": "First, for clinical trial NCT01564537 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 18, 2037",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 573,
    "question": "For clinical trial NCT01564537 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Oct 3, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 574,
    "question": "For clinical trial NCT01564537, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 575,
    "question": "For clinical trial NCT01850524. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DEXAMETHASONE",
    "task_name": "Ingredient"
  },
  {
    "id": 576,
    "question": "First, for clinical trial NCT01850524 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "DEXCEL PHARMA TECHNOLOGIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 577,
    "question": "First, for clinical trial NCT01850524 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 18, 2037",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 578,
    "question": "For clinical trial NCT01850524 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Oct 3, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 579,
    "question": "For clinical trial NCT01850524, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 580,
    "question": "For clinical trial NCT00115700. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with C\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "CYCLOPHOSPHAMIDE",
    "task_name": "Ingredient"
  },
  {
    "id": 581,
    "question": "First, for clinical trial NCT00115700 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "EUGIA PHARMA SPECIALITIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 582,
    "question": "First, for clinical trial NCT00115700 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jun 26, 2035",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 583,
    "question": "For clinical trial NCT00115700 among the more effective regimen ingredients, identify which ingredient starts with the letter C.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 584,
    "question": "For clinical trial NCT00115700, review the more effective regimen ingredients and identify which ingredient starts with the letter C.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 585,
    "question": "For clinical trial NCT02993523. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with V\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "VENETOCLAX",
    "task_name": "Ingredient"
  },
  {
    "id": 586,
    "question": "First, for clinical trial NCT02993523 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "ABBVIE INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 587,
    "question": "First, for clinical trial NCT02993523 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 29, 2032",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 588,
    "question": "For clinical trial NCT02993523 among the more effective regimen ingredients, identify which ingredient starts with the letter V.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "May 15, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 589,
    "question": "For clinical trial NCT02993523, review the more effective regimen ingredients and identify which ingredient starts with the letter V.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "58.59000015258789",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 590,
    "question": "For clinical trial NCT00222677. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with A\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "ASPIRIN; OMEPRAZOLE",
    "task_name": "Ingredient"
  },
  {
    "id": 591,
    "question": "First, for clinical trial NCT00222677 among the more effective regimen ingredients, identify which ingredient starts with the letter A.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "GENUS LIFE SCIENCES INC",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 592,
    "question": "First, for clinical trial NCT00222677 among the more effective regimen ingredients, identify which ingredient starts with the letter A.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Jan 2, 2033",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 593,
    "question": "For clinical trial NCT00222677 among the more effective regimen ingredients, identify which ingredient starts with the letter A.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 594,
    "question": "For clinical trial NCT00222677, review the more effective regimen ingredients and identify which ingredient starts with the letter A.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 595,
    "question": "For clinical trial NCT00006232. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with D\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "DEXAMETHASONE",
    "task_name": "Ingredient"
  },
  {
    "id": 596,
    "question": "First, for clinical trial NCT00006232 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "DEXCEL PHARMA TECHNOLOGIES LTD",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 597,
    "question": "First, for clinical trial NCT00006232 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Dec 18, 2037",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 598,
    "question": "For clinical trial NCT00006232 among the more effective regimen ingredients, identify which ingredient starts with the letter D.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": "Oct 3, 2026",
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 599,
    "question": "For clinical trial NCT00006232, review the more effective regimen ingredients and identify which ingredient starts with the letter D.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "Not_Listed",
    "task_name": "Open_on_Approval"
  },
  {
    "id": 600,
    "question": "For clinical trial NCT00685646. Among the more effective regimen ingredients; find which is the ingredient with the first letter start with Z\n return only the name of the ingredient or unknown in all CAPS in the format of INGREDIENT: name",
    "answer": "ZOLEDRONIC ACID",
    "task_name": "Ingredient"
  },
  {
    "id": 601,
    "question": "First, for clinical trial NCT00685646 among the more effective regimen ingredients, identify which ingredient starts with the letter Z.\n\nThen, find which company has the latest FDA approval date up till Dec, 2024 for this identified ingredient. Note that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals. \nReturn only the company name in format of COMPANY: name.",
    "answer": "NOVARTIS PHARMACEUTICALS CORP",
    "task_name": "Applicant_Full_Name"
  },
  {
    "id": 602,
    "question": "First, for clinical trial NCT00685646 among the more effective regimen ingredients, identify which ingredient starts with the letter Z.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its patent expiration date?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nReturn only the date only the year YYYY format of date: YYYY.",
    "answer": "Nov 29, 2025",
    "task_name": "Patent_Expire_Date_Text"
  },
  {
    "id": 603,
    "question": "For clinical trial NCT00685646 among the more effective regimen ingredients, identify which ingredient starts with the letter Z.\n\nThen, for this identified ingredient that was last approved up till Dec, 2024, when is its exclusivity date according to the FDA?\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\nIf no exclusivity date exists or if it's not available, respond with 'DATE: NA'. Otherwise, return only the date in MM-DD-YYYY format of date: MM-DD-YYYY.",
    "answer": null,
    "task_name": "Exclusivity_Date"
  },
  {
    "id": 604,
    "question": "For clinical trial NCT00685646, review the more effective regimen ingredients and identify which ingredient starts with the letter Z.\n\nThen, determine which pharmaceutical company received the most recent FDA approval (up until December 2024) for this identified ingredient.\nNote that we are only look for overall FDA drug approval, not new indidcation, not supplemental approvals.\n\nIf this company is listed on any US stock market (including over-the-counter markets), provide:\n1. The stock ticker symbol\n2. The opening stock price on the FDA approval date\n\nIf the company is not listed on any US stock market, please indicate \"NOT LISTED\".",
    "answer": "31.94444465637207",
    "task_name": "Open_on_Approval"
  }
]